Items tagged with HIV coinfection
Pretoria, 23 March 2018 – Unitaid and South Africa’s National Department of Health have launched a partnership to accelerate the country’s efforts to prevent and treat HIV and tuberculosis. South Africa is home to the world’s biggest HIV/AIDS epidemic, as well as one of the highest TB burdens.
A large proportion of hospitalised HIV-positive people in sub-Saharan Africa have experienced the failure of first-line antiretroviral therapy (ART), according to a study published in the journal Clinical Infectious Diseases.
In a hospital serving an urban population, more than a third of patients with a confirmed TB diagnosis also had HIV. Of those, nearly three quarters had been diagnosed with the virus that greatly increased their risks of becoming sick from the world’s oldest airborne infection, with a median of six years between a test showing they had HIV, and a test showing they had become sick with tuberculosis. Among those 73 patients already diagnosed with HIV, only 10 were accessing the antiretroviral treatment that protected their immune systems and offered them a defense against TB. Even at the end of their treatment, when 74 patients had accessed antiretroviral medicine, the treatment had been effective enough to suppress the virus in only a little more than half the patients. Three years after they completed the treatment, fewer than a third had maintained continuous treatment for HIV, or suppressed viruses. The high rates HIV/TB co-infection, and low rates of treatment, as well as of viral suppression, compare unfavorably to those of some African countries confronting the highest burden of both diseases.
Study finds increased survival and cure rates for patients with HIV and MDR-TB when infections treated concurrently (post)
Patients co-infected with HIV and multidrug-resistant tuberculosis (MDR-TB) can achieve similar survival and tuberculosis cure rates to those infected with MDR-TB but not HIV when treated concurrently for both infections, according to a new study published in the journal Clinical Infectious Diseases. The study was led by investigators at the Emory Rollins School of Public Health, in collaboration with Albert Einstein College of Medicine, the University of KwaZulu-Natal and the U.S. Centers for Disease Control and Prevention.
Call for submission of country case studies on TB and HIV for thematic segment of the 42nd UNAIDS PCB (post)
At its 41st meeting, the UNAIDS Program Coordinating Board (PCB) agreed that the theme for its 42nd meeting will be: “Ending tuberculosis and AIDS – a joint response in the era of the Sustainable Development Goals”
South Africa has the highest burden of HIV-associated TB. In an interview published in the Bulletin of the World Health Organization, Yogan Pillay tells how the health ministry has brought the two programmes and services together.
Worldwide, tuberculosis (TB) remains the leading cause of morbidity and mortality for patients living with HIV (PLWH). As of 2009, the World Health Organization (WHO) recommended daily antituberculosis therapy (ATT) for TB in PLWH, while the standard of care in India at the time was intermittent, or thrice-weekly, ATT in those patients.
TB CAB, TAG public comment in response to FDA guidance to TB drug developers (post with simple image)
Comment on Guidance for industry on pulmonary tuberculosis: Developing drugs for treatment.
SADC must unite to defeat scourge of TB: Motsoaledi (post with simple image)
Plans to implement screening programmes and regional treatment initiatives to combat tuberculosis with the same fervour as HIV/Aids are in the pipeline, Health Minister Aaron Motsoaledi said.
ERS/WHO TB Consilium on difficult-to-treat TB and TB/HIV cases (post with simple image)
If are you a physician dealing with complex M/XDR-TB, TB/HIV and other difficult-to-treat TB cases, the ERS/WHO TB Consilium can help you to manage them, free of charge.
Page 26 of 33 · Total posts: 0←First 25 26 27 Last→